FDA NDC Directory · JSON-LD · Markdown

Diazoxide

NDC 0254-1010 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerPar Health USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210799
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDIAZOXIDE (50 mg/mL)
Marketing started20200721
Package count1

External sources

Source: openFDA. Public-domain (CC0).